What is the global market size of Biopharmaceuticals Third Party Logistics 3pl Market?

Biopharmaceuticals Third Party Logistics 3pl Market size was valued at USD 119.8 billion in 2021 and is poised to grow from USD 125.8 billion in 2022 to USD 198.5 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030).

Global Biopharmaceuticals Third Party Logistics 3pl Market Size, Share, Growth Analysis, By Supply chain(cold chain and non-cold chain), By Service type(transportation, warehousing and storage) - Industry Forecast 2024-2031

Report ID: SQMIG35C2014 | Region: Global | Published Date: February, 2024
Pages: 255 | Tables: 60 | Figures: 75

Global Biopharmaceuticals Third Party Logistics 3pl Market Regional Insights

North America's market was the most profitable and held the largest share in 2021, accounting for more than 42.0% of total revenue generated worldwide. This is primarily due to the region's dominance in the biologics and pharmaceutical medication markets, as well as an increase in the number of biopharmaceuticals shipped out of and brought into the region. Furthermore, due to the high cost of medical treatment, the region has a relatively high rate of adoption of various cutting-edge technologies.

The Asia-Pacific region's fastest growth is due to a few factors, including an increasing need for pharmaceuticals among an ageing population, the adoption of technologically enhanced services, and the developing economic conditions in emerging countries such as China and India. Furthermore, the fact that an increasing number of patents will expire in the coming years indicates that there will be a significant shift in the market share of medicine sales away from the original brand manufacturer and toward generic ones. This aspect is expected to increase pharmaceutical sales, as well as import and export. The prevalence of a growing number of diseases is driving up demand for pharmaceuticals and biologics. Because of the high prevalence of type 2 diabetes patients in Asia-Pacific, for example, there is a greater need for insulin in those regions.

Global Biopharmaceuticals Third Party Logistics 3pl Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopharmaceuticals Third Party Logistics 3pl Market size was valued at USD 119.8 billion in 2019 and is poised to grow from USD 125.8 billion in 2023 to USD 198.5 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The market is highly fragmented, with a large number of players. This fragmentation makes it difficult for major players to enter a few countries around the world. As a result, the big players are consolidating, which will allow them to accept modern technologies from small or regional players and expand their global presence. 'FedEx', ' DHL Supply Chain & Global Forwarding ', ' XPO Logistics ', ' UPS Supply Chain Solutions ', ' DB Schenker ', ' Kuehne + Nagel ', ' AmerisourceBergen ', ' CEVA Logistics ', ' Cardinal Health ', ' Expeditors International ', ' DSV Panalpina ', ' GEODIS ', ' NFI Industries ', ' Agility ', ' Penske Logistics ', ' Hellmann Worldwide Logistics ', ' Ryder ', ' Syncreon ', ' C.H. Robinson Worldwide ', ' CHAMP Cargosystems '

The growing demand for efficient logistics solutions that can safely transport temperature-sensitive medications is expected to drive the growth of the biopharmaceutical third-party logistics (3PL) market. The introduction of a wide range of biologics and biosimilars, all of which require temperature-controlled logistics service to be distributed, is expected to be the driving force behind the growth of the biopharmaceutical third-party logistics market. The increased adoption of automation in manufacturing facilities in an effort to reduce operational costs is driving demand for third-party logistics services. Furthermore, the rising prevalence of chronic diseases is driving up demand for biologics, which is fuelling the growth of the biopharmaceutical third-party logistics (3PL) market.

Companies are investing more money in R&D to develop efficient value-added services in order to meet the growing demand for advanced logistic services in the biopharmaceutical industry. Smart sensor technology refers to the technology that measures the ambient conditions inside the vehicle. DHL is able to improve its distribution network in part because of the implementation of technologically advanced devices.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Biopharmaceuticals Third Party Logistics 3pl Market Size, Share, Growth Analysis, By Supply chain(cold chain and non-cold chain), By Service type(transportation, warehousing and storage) - Industry Forecast 2024-2031

Global Biopharmaceuticals Third Party Logistics 3pl Market Regional Insights

Global Biopharmaceuticals Third Party Logistics 3pl Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Biopharmaceuticals Third Party Logistics 3pl Market?

Who are the key vendors in the Global Biopharmaceuticals Third Party Logistics 3pl Market?

What is the key driver of Global Biopharmaceuticals Third Party Logistics 3pl Market?

What is the key market trend for Global Biopharmaceuticals Third Party Logistics 3pl Market?

Which region accounted for the largest share in Global Biopharmaceuticals Third Party Logistics 3pl Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300